Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.
about
Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular CarcinomaRecent advances in multidisciplinary management of hepatocellular carcinomaClinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and futureLocoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.Effect of curcumin on vascular endothelial growth factor in hypoxic HepG2 cells via the insulin-like growth factor 1 receptor signaling pathway.
P2860
Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Combination of local transcath ...... able hepatocellular carcinoma.
@en
type
label
Combination of local transcath ...... able hepatocellular carcinoma.
@en
prefLabel
Combination of local transcath ...... able hepatocellular carcinoma.
@en
P2860
P356
P1433
P1476
Combination of local transcath ...... able hepatocellular carcinoma.
@en
P2093
Jean-Francois H Geschwind
P2860
P304
P356
10.1159/000343835
P50
P577
2012-11-01T00:00:00Z